Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study.

Wataru FukuokayaYuhei KoikeYuji YataKazumasa KomuraTaizo UchimotoTakuya TsujinoMasanobu SarutaKiyoshi TakaharaKazutoshi FujitaTakafumi MinamiTakahiro AdachiYosuke HirasawaTakeshi HashimotoYoshio Ohno Hirotsugu UemuraRyoichi ShirokiHaruhito AzumaTakahiro Kimura

Published in: International journal of urology : official journal of the Japanese Urological Association (2023)

This study describes the characteristics and outcomes of patients with previously treated advanced urothelial cancer receiving EV. The findings demonstrate that EV showed robust anti-tumor activity and had manageable safety profiles outside the clinical trial setting.

Keyphrases

papillary thyroid
clinical trial
squamous cell
high grade
double blind
randomized controlled trial
cross sectional
metabolic syndrome
open label